HAL vs RLAY · P/E 9.3, $19.05B cap vs rev $10.0M
Halliburton Company (HAL) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported RLAY revenue for 2024-12-31 was $10.0M. Net income was -$337.7M. Revenue was down 60.8% from 2023-12-31 to 2024-12-31. RLAY currently screens at market cap $3.39B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the HAL and RLAY stock pages for the full models.
Not investment advice.